QuickView for glutathione transmembrane transporter activity (biogroup)

1. Drug target sets for approved compounds
2. OMIM - Deafness and Ear Disorders
3. Hepatic progenitor HepaRG cells treated with compounds that cause liver injury
4. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
5. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)

There were no matches for glutathione transmembrane transporter activity

1. Inhaled Glutathione (GSH) Versus Placebo in Cystic Fibrosis
2. Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
3. Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
4. β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis